Cogent Biosciences Inc (NASDAQ: COGT) on Monday, soared 7.51% from the previous trading day, before settling in for the closing price of $4.26. Within the past 52 weeks, COGT’s price has moved between $3.72 and $12.61.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Healthcare Sector giant saw their annual sales slid by -33.00% over the last five years. The company achieved an average annual earnings per share of 9.38%. With a float of $95.39 million, this company’s outstanding shares have now reached $110.46 million.
The firm has a total of 205 workers. Let’s measure their productivity. In terms of profitability, gross margin is 0.0%, operating margin of 0.0%, and the pretax margin is 0.0%.
Cogent Biosciences Inc (COGT) Insider Activity
Observing investor behavior towards Biotechnology industry stocks is more important than anything else. The insider ownership of Cogent Biosciences Inc is 16.22%, while institutional ownership is 91.53%. The most recent insider transaction that took place on Jan 14 ’25, was worth 332,412. In this transaction Chief Commercial Officer of this company bought 43,750 shares at a rate of $7.60, taking the stock ownership to the 45,848 shares.
Cogent Biosciences Inc (COGT) Earnings and Forecasts
Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.56 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 9.38% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 31.60% during the next five years compared to 10.02% growth over the previous five years of trading.
Cogent Biosciences Inc (NASDAQ: COGT) Trading Performance Indicators
Cogent Biosciences Inc (COGT) is currently performing well based on its current performance indicators. A quick ratio of 5.32 was reported for the most recent quarter.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -2.47, a number that is poised to hit -0.58 in the next quarter and is forecasted to reach -1.87 in one year’s time.
Technical Analysis of Cogent Biosciences Inc (COGT)
Analysing the last 5-days average volume posted by the [Cogent Biosciences Inc, COGT], we can find that recorded value of 1.66 million was better than the volume posted last year of 1.43 million. As of the previous 9 days, the stock’s Stochastic %D was 24.49%. Additionally, its Average True Range was 0.52.
During the past 100 days, Cogent Biosciences Inc’s (COGT) raw stochastic average was set at 12.60%, which indicates a significant decrease from 26.75% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 97.37% in the past 14 days, which was higher than the 68.37% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $7.03, while its 200-day Moving Average is $8.98. Now, the first resistance to watch is $4.71. This is followed by the second major resistance level at $4.84. The third major resistance level sits at $5.06. If the price goes on to break the first support level at $4.36, it is likely to go to the next support level at $4.14. Should the price break the second support level, the third support level stands at $4.01.
Cogent Biosciences Inc (NASDAQ: COGT) Key Stats
Market capitalization of the company is 521.43 million based on 113,850K outstanding shares. Right now, sales total 0 K and income totals -255,860 K. The company made 0 K in profit during its latest quarter, and -67,930 K in sales during its previous quarter.
